At a glance
- Originator Bioprojet
- Class Analgesics; Antiepileptic drugs; Antihistamines; Neuroprotectants; Nootropics
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 08 Mar 2000 No-Development-Reported for CNS disorders in France (Unknown route)
- 14 May 1997 New profile
- 14 May 1997 Preclinical development for CNS disorders in France (Unknown route)